Long-Term Data for Recurrent Respiratory Papillomatosis Therapy
Updated clinical data demonstrates that Papzimeos for adults with Recurrent Respiratory Papillomatosis (RRP) can maintain complete responses for more than four years.
Category: Other Chronic Diseases
Other Chronic Diseases
Latest
Long-Term Data for Recurrent Respiratory Papillomatosis Therapy
Updated clinical data demonstrates that Papzimeos for adults with Recurrent Respiratory Papillomatosis (RRP) can maintain complete responses for more than four years.
Read More
Inhaled Molgramostim Improved Exercise Capacity
Phase 3 clinical trial data shows improvements in walking distance and duration for patients with autoimmune pulmonary alveolar proteinosis treated with inhaled molgramostim.
Read More
Alpha-1 Drug Candidate Superior to Standard Care
Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Read More
Pediatric Pulmonary Rehab Improves Exercise Capacity, QoL
Pediatric pulmonary rehab programs enhance exercise capacity, strength, and quality of life even when lung function measurements remain stable.
Read More
FDA Approves Benralizumab for Hypereosinophilic Syndrome
Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.
Read More
Bronchiectasis + Chronic Rhinosinusitis Patients More Likely to Have P. aeruginosa in Mucus
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
Why Some Alpha-1 Patients Develop Liver Disease
A newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
Read More
TV Host Promotes Bronchiectasis Awareness
Insmed Inc has partnered with TV host Ty Pennington to launch “Suspect Bronchiectasis (Suspect BE),” an educational initiative aimed at increasing awareness and proper diagnosis of bronchiectasis.
Read More
ATS Launches Initiative to Improve Bronchiectasis Diagnosis
An ATS study will analyze electronic health records across seven academic medical systems to identify misdiagnosed bronchiectasis cases.
Read More
Bronchopulmonary Dysplasia: Predicting Neonatal Respiratory Support
Researchers identified specific milestones that help clinicians determine when infants with bronchopulmonary dysplasia (BPD) will no longer require respiratory support.
Read More
Obesity Decreases Lung Function in Seniors
New research indicates that obesity significantly impairs pulmonary measures in seniors, potentially contributing to shortness of breath and exercise intolerance.
Read More
Clinician Bias Linked to Opioid Stigma in Sickle Cell Care
Negative descriptors in clinician notes for sickle cell patients are closely associated with stigma surrounding opioid use.
Read More
NIOSH Continues Mobile Health Screenings for Coal Miners
The federal program provides free respiratory testing to support the early detection of black lung disease in mining communities.
Read More
Positive Ph3 Arikayce Data for MAC Lung Disease
The ENCORE study showed that adding an inhaled amikacin suspension to multidrug therapy improved respiratory symptoms and increased culture conversion rates.
Read More
Age 19 Triggers Medicaid Disenrollment
Approximately 13% of young adults with complex medical conditions and 36% without such conditions lost Medicaid coverage at age 19.
Read More
Study Reveals How Lungs Age
Certain types of lung cells are especially vulnerable to aging, a finding that could inform treatments that target the defective cells.
Read More
Raising Awareness of Idiopathic Subglottic Stenosis
Idiopathic subglottic stenosis (iSGS) is a rare airway disease that causes scar tissue to narrow the airway below the vocal cords and primarily affects women and is often misdiagnosed as asthma.
Read More
Mepolizumab May Be Protective Against Small Airway Dysfunction Exacerbation Risks in Children
Airway resistance was associated with increased exacerbation rates in the placebo group but not the mepolizumab treatment groups.
Read More
Lung Comorbidities Influence ILD Risk in Rheumatoid Arthritis
When comorbidity burden was assessed using the Rheumatic Disease Comorbidity Index (RDCI), higher scores were significantly associated with ILD development.
Read More
Airborne Toxins Trigger Unique Chronic Rhinosinusitis in Veterans
Veterans with chronic rhinosinusitis (CRS) who were exposed to burn pits and other toxins show a marked increase in sinus mast cells.
Read More
Quantitative Mucin Index: a New Metric to Monitor Lung Health
The Quantitative Mucin Index (MUCQ) of the Lung analyzes sputum and other lung mucus samples to detect airway mucus abnormalities, assess disease risk, and track disease progression in patients over time.
Read More
PCD Center Adds LRS Machine for Genetic Testing
Recent funding has allowed Children’s Hospital of Chicago’s Primary Ciliary Dyskinesia Center to purchase its first Long Read Sequencing (LRS) machine to aid PCD genetic testing.
Read More
Half of Commercially Insured Patients Have Chronic Conditions
The majority (57.5%) of commercially insured patients had at least one chronic condition in 2024, with high cholesterol the most common affliction.
Read More
New Standard of Care Recommended for Recurrent Respiratory Papillomatosis
Papzimeos (zopapogene imadenovec) is recommended as the new first-line treatment for adults with recurrent respiratory papillomatosis (RRP), which affects an estimated 27,000 US adults.
Read More